Stockreport

Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site

Kiromic BioPharma, Inc.  (KRBP) 
PDF HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) announces that UPMC in Pittsburgh, Pennsylvania has been activated as th [Read more]